Know our history, mission and values.
Founded in 2009, AméricasAmigas is a Non-Governmental Organization (NGO) and Human Rights Promoting Entity.
Its mission is to reduce the rates of breast cancer mortality among Brazilian women, especially those of the low-income population, through the detection and early diagnosis of the disease.
NGO Américas Amigas donates mammograms, mammographs, ultrasound and biopsy tests, trains professionals in the breast cancer field and promotes awareness and information initiatives on breast cancer. From 2009 to the present, Américas Amigas has donated 23 mammographs.
Today we are proud to have as partners entities that embrace our cause and help us save lives by promoting early detection and diagnosis of the disease that, if discovered in time, has a 95% chance of cure. Thanks to the donated equipment, more than 850.000 mammograms were provided by the beneficiaries, including two ships of the Brazilian Navy, which provide medical care to the populations living in the Amazon and Pará rivers.
In partnership with the Cancer Hospital of Patrocínio - Dr. José Figueiredo, Américas Amigas has taken the opportunity of early detection of breast cancer to women in the states of Minas Gerais and São Paulo, through a mobile unit.
In addition, through its Training Program, the association has already offered more than 30.000 hours of training for mammography professionals from public and philanthropic institutions in the country. Through its Exams Donation Program, Américas Amigas has enabled the detection and early diagnosis of the disease among low-income Brazilians.
Promote, in the national territory, activities to reduce mortality due to breast cancer, benefiting mainly the low-income population, through the availability of early awareness, prevention, detection and diagnosis of the disease.
Segundo o INCA (Instituto Nacional de Câncer), o câncer de mama não tem uma causa única.
A mamografia é o exame mais comum para detectar a presença de nódulos ou microcalcificações na mama. O exame deve ser feito anualmente por mulheres acima de 40 anos, como um método de detecção precoce do câncer de mama.